1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one

C25H33N3O3S — CID 158485023

IUPAC1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one
SMILESCC(c1cc(S(=O)(=O)CC(=O)Cc2c3c(cc4c2CCC4)CCC3)nn1C1CC1)N(C)C
InChIInChI=1S/C25H33N3O3S/c1-16(27(2)3)24-14-25(26-28(24)19-10-11-19)32(30,31)15-20(29)13-23-21-8-4-6-17(21)12-18-7-5-9-22(18)23/h12,14,16,19H,4-11,13,15H2,1-3H3
InChIKeyAPLJBYGQKMOUCF-UHFFFAOYSA-N
MW455.62 g/mol
LogP3.40
Rot. Bonds8

About 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one

1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one (PubChem CID 158485023) has the molecular formula C25H33N3O3S and a molecular weight of 455.62 g/mol. Its IUPAC name is 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one.

Molecular Properties

Compound Name1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one
PubChem CID158485023
Molecular FormulaC25H33N3O3S
Molecular Weight455.62 g/mol
Exact Mass455.22
IUPAC Name1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one
SMILESCC(c1cc(S(=O)(=O)CC(=O)Cc2c3c(cc4c2CCC4)CCC3)nn1C1CC1)N(C)C
InChIInChI=1S/C25H33N3O3S/c1-16(27(2)3)24-14-25(26-28(24)19-10-11-19)32(30,31)15-20(29)13-23-21-8-4-6-17(21)12-18-7-5-9-22(18)23/h12,14,16,19H,4-11,13,15H2,1-3H3
InChIKeyAPLJBYGQKMOUCF-UHFFFAOYSA-N
XLogP3.40
TPSA72.27 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500455.62
LogP ≤ 53.40
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one?
The IUPAC name of 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one (CID 158485023) is 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one.
What is the SMILES notation for 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one?
The canonical SMILES for 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one is CC(c1cc(S(=O)(=O)CC(=O)Cc2c3c(cc4c2CCC4)CCC3)nn1C1CC1)N(C)C.
What is the InChIKey of 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one?
The InChIKey is APLJBYGQKMOUCF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H33N3O3S/c1-16(27(2)3)24-14-25(26-28(24)19-10-11-19)32(30,31)15-20(29)13-23-21-8-4-6-17(21)12-18-7-5-9-22(18)23/h12,14,16,19H,4-11,13,15H2,1-3H3.
What are the key properties of 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one?
1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one has a molecular weight of 455.62 g/mol, XLogP of 3.40, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[1-cyclopropyl-5-[1-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)propan-2-one is sourced from PubChem (CID 158485023), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).